Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Sui Shen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Concepts & Ideas
Chemicals & Drugs
Devices
Disorders
Living Beings
Anatomy
Sign-in to see full Profile
Network (preview)
49
DeNardo, Gerald
48
DeNardo, Sally
26
O'Donnell, Robert
20
Kukis, David
20
Yuan, Aina
17
Kroger, Linda
17
Meredith, Ruby
17
Duan, Jun
16
Lamborn, Kathleen
15
LoBuglio, Albert
15
Denardo, DA
15
Brezovich, Ivan
13
Goldstein, Desiree
13
Meares, Claude
11
Khazaeli, Muhammad
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Sui Shen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Wu Xingen; Spencer Sharon A; Shen Sui; Fiveash John B; Duan Jun; Brezovich Ivan A
Development of an accelerated GVF semi-automatic contouring algorithm for radiotherapy treatment planning.
Computers in biology and medicine 2009;39(7):650-6.
-
2009: Fisher Darrell R; Shen Sui; Meredith Ruby F
MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(4):644-52.
-
2009: Choi Chang Hyun; Ye Sung-Joon; Parsai E Ishmael; Shen Sui; Meredith Ruby; Brezovich Ivan A; Ove Roger
Dose optimization of breast balloon brachytherapy using a stepping 192Ir HDR source.
Journal of applied clinical medical physics / American College of Medical Physics 2009;10(1):2903.
-
2008: Duan Jun; Kim Robert Y; Elassal Shaaban; Lin Hui-Yi; Shen Sui
Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
International journal of radiation oncology, biology, physics 2008;71(3):765-71.
-
2008: Meredith Ruby F; Shen Sui; Forero Andres; LoBuglio Albert
A method to correct for radioactivity in large vessels that overlap the spine in imaging-based marrow dosimetry of lumbar vertebrae.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(2):279-84.
-
2007: Shah Jatin; Wang Wenquan; Harrough V Douglas; Saville Wayne; Meredith Ruby; Shen Sui; Mueh John; Lister John; Jasthy Sri; Maggass Gregory; McKay Charles; Krumdieck Richard; Tharp Morgan; Winter Christine; Gregory Stephanie; Buchholz William; Awasthi Sanjay; Jacobs Samuel; Chung Harold; Egner James; Lobuglio Albert F; Forero Andres
Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma.
Leukemia & lymphoma 2007;48(9):1736-44.
-
2007: Kim Robert Y; Shen Sui; Duan Jun
Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
Brachytherapy 2007;6(3):187-94.
-
2007: Ahmed Raef S; Shen Sui; Ove Roger; Duan Jun; Fiveash John B; Russo Suzanne M
Intensity modulation with respiratory gating for radiotherapy of the pleural space.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2007;32(1):16-22.
-
2006: Shah Jatin J; Meredith Ruby; Shen Sui; Nabors Burt; Lobuglio Albert; Yester Michael; Forero Andres
Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy.
Clinical lymphoma & myeloma 2006;7(3):236-8.
-
2006: Lehmann Joerg; DeNardo Gerald L; Yuan Aina; Shen Sui; O'Donnell Robert T; Richman Carol M; DeNardo Sally J
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.
International journal of radiation oncology, biology, physics 2006;66(4):1192-8.
-
2006: Mamelak Adam N; Rosenfeld Steven; Bucholz Richard; Raubitschek Andrew; Nabors L Burt; Fiveash John B; Shen Sui; Khazaeli M B; Colcher David; Liu An; Osman Medhat; Guthrie Bart; Schade-Bijur Susan; Hablitz Diana M; Alvarez Vernon L; Gonda Matthew A
Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3644-50.
-
2006: Popple Richard A; Weinber Rebecca; Antolak John A; Ye Sung-Joon; Pareek Prem N; Duan Jun; Shen Sui; Brezovich Ivan A
Comprehensive evaluation of a commercial macro Monte Carlo electron dose calculation implementation using a standard verification data set.
Medical physics 2006;33(6):1540-51.
-
2006: Duan Jun; Shen Sui; Fiveash John B; Popple Richard A; Brezovich Ivan A
Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study.
Medical physics 2006;33(5):1380-7.
-
2006: Breitz Hazel B; Wendt Richard E; Stabin Michael S; Shen Sui; Erwin William D; Rajendran Joseph G; Eary Janet F; Durack Lawrence; Delpassand Ebrahim; Martin William; Meredith Ruby F
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):534-42.
-
2005: Shen Sui; DeNardo Gerald L; Yuan Aina; Hartmann-Siantar Christine; O'Donnell Robert T; DeNardo Sally J
Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody.
Cancer biotherapy & radiopharmaceuticals 2005;20(6):662-70.
-
2005: Rogers Buck E; Roberson Peter L; Shen Sui; Khazaeli M B; Carpenter Mark; Yokoyama Shigeru; Brechbiel Martin W; LoBuglio Albert F; Buchsbaum Donald J
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Cancer biotherapy & radiopharmaceuticals 2005;20(5):502-13.
-
2005: Forero Andres; Meredith Ruby F; Khazaeli M B; Shen Sui; Grizzle William E; Carey Delicia; Busby Elizabeth; LoBuglio Albert F; Robert Francisco
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Cancer biotherapy & radiopharmaceuticals 2005;20(5):467-78.
-
2005: Richman Carol M; Denardo Sally J; O'Donnell Robert T; Yuan Aina; Shen Sui; Goldstein Desiree S; Tuscano Joseph M; Wun Ted; Chew Helen K; Lara Primo N; Kukis David L; Natarajan Arutselvan; Meares Claude F; Lamborn Kathleen R; DeNardo Gerald L
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5920-7.
-
2005: Forero-Torres Andres; Shen Sui; Breitz Hazel; Sims Robert B; Axworthy Don B; Khazaeli M B; Chen Kuang-Ho; Percent Ivor; Besh Stephen; LoBuglio Albert F; Meredith Ruby F
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
Cancer biotherapy & radiopharmaceuticals 2005;20(4):379-90.
-
2005: Shen Sui; DeNardo Sally J; Richman Carol M; Yuan Aina; Siantar Christine Hartmann; O'Donnell Robert T; Kroger Linda A; DeNardo Gerald L
Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1034-41.
-
2005: Shen Sui; Meredith Ruby F
Clinically useful marrow dosimetry for targeted radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2005;20(2):119-22.
-
2005: Shen Sui; Forero Andres; LoBuglio Albert F; Breitz Hazel; Khazaeli M B; Fisher Darrell R; Wang Wenquan; Meredith Ruby F
Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(4):642-51.
-
2005: Hockaday David C; Shen Sui; Fiveash John; Raubitschek Andrew; Colcher David; Liu An; Alvarez Vern; Mamelak Adam N
Imaging glioma extent with 131I-TM-601.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(4):580-6.
-
2005: Shen Sui; Meredith Ruby; Duan Jun; Forero Andres; Breitz Hazel; Khazaeli M B; Brezovich Ivan; LoBuglio Albert
Testicular uptake and radiation dose in patients receiving Zevalin and Pretarget CC49Fusion protein.
Cancer biotherapy & radiopharmaceuticals 2005;20(1):110-8.
-
2005: Shen Sui; Khazaeli M B; Gillespie G Yancey; Alvarez Vernon L
Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
Journal of neuro-oncology 2005;71(2):113-9.
-
2005: Popple Richard A; Brezovich Ivan A; Duan Jun; Shen Sui; Pareek Prem N; Ye Sung-Joon
Determination of field size-dependent wedge factors from a few selected measurements.
Journal of applied clinical medical physics / American College of Medical Physics 2005;6(1):51-60.
-
2004: de Bono Johann S; Tolcher Anthony W; Forero Andre; Vanhove Gertrude F A; Takimoto Chris; Bauer Robert J; Hammond Lisa A; Patnaik Amita; White Mark L; Shen Sui; Khazaeli Muhammad B; Rowinsky Eric K; LoBuglio Albert F
ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7555-65.
-
2004: Duan Jun; Shen Sui; Spencer Sharon A; Ahmed Raef S; Popple Richard A; Ye Sung-Joon; Brezovich Ivan A
A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT.
International journal of radiation oncology, biology, physics 2004;60(3):959-72.
-
2004: Ye Sung-Joon; Brezovich Ivan A; Shen Sui; Kim Siyong
Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer.
International journal of radiation oncology, biology, physics 2004;60(2):672-7.
-
2004: Ye Sung-Joon; Brezovich Ivan A; Shen Sui; Duan Jun; Popple Richard A; Pareek Prem N
Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
Medical physics 2004;31(7):2097-106.
-
2004: Forero Andres; Weiden Paul L; Vose Julie M; Knox Susan J; LoBuglio Albert F; Hankins Jordan; Goris Michael L; Picozzi Vincent J; Axworthy Don B; Breitz Hazel B; Sims Robert B; Ghalie Richard G; Shen Sui; Meredith Ruby F
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Blood 2004;104(1):227-36.
-
2003: Shen Sui; Duan Jun; Fiveash John B; Brezovich Ivan A; Plant Brian A; Spencer Sharon A; Popple Richard A; Pareek Prem N; Bonner James A
Validation of target volume and position in respiratory gated CT planning and treatment.
Medical physics 2003;30(12):3196-205.
-
2003: Forero Andres; Meredith Ruby F; Khazaeli M B; Carpenter D Mark; Shen Sui; Thornton Jennifer; Schlom Jeffrey; LoBuglio Albert F
A novel monoclonal antibody design for radioimmunotherapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):751-9.
-
2003: Popple Richard A; Kim Robert Y; Pareek Prem; Duan Jun; Shen Sui; Brezovich Ivan A
Custom step wedge blocking using dynamic multileaf collimation for parametrial pelvic boost irradiation following brachytherapy for carcinoma of the cervix.
Medical physics 2003;30(10):2699-702.
-
2003: Duan Jun; Shen Sui; Fiveash John B; Brezovich Ivan A; Popple Richard A; Pareek Prem N
Dosimetric effect of respiration-gated beam on IMRT delivery.
Medical physics 2003;30(8):2241-52.
-
2003: Meredith Ruby; Shen Sui; Macey Daniel; Khazaeli M B; Carey Delicia; Robert Francisco; LoBuglio Albert
Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(3):393-404.
-
2003: DeNardo Gerald; Yuan Aina; Goldstein Desiree; Richman Carol; O'Donnell Robert; Shen Sui; Hartmann Siantar Christine; DeNardo Sally
Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):231-7.
-
2003: Shen Sui; Meredith Ruby F; Duan Jun; Brezovich Ivan; Khazaeli M B; LoBuglio Albert F
Comparison of methods for predicting myelotoxicity for non-marrow targeting I-131-antibody therapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):209-15.
-
2002: Brezovich Ivan A; Popple Richard A; Duan Jun; Shen Sui; Pareek Prem N
Assaying 192Ir line sources using a standard length well chamber.
Medical physics 2002;29(11):2692-7.
-
2002: Popple Richard A; Ove Roger; Shen Sui
Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.
International journal of radiation oncology, biology, physics 2002;54(3):921-7.
-
2002: Alvarez Ronald D; Huh Warner K; Khazaeli M B; Meredith Ruby F; Partridge Edward E; Kilgore Larry C; Grizzle William E; Shen Sui; Austin J Max; Barnes Mack N; Carey Delicia; Schlom Jeffrey; LoBuglio Albert F
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2806-11.
-
2002: Shen Sui; Meredith Ruby F; Duan Jun; Macey Daniel J; Khazaeli M B; Robert Francisco; LoBuglio Albert F
Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(9):1245-53.
-
2002: Shen Sui; Duan Jun; Meredith Ruby F; Buchsbaum Donald J; Brezovich Ivan A; Pareek Prem N; Bonner James A
Model prediction of treatment planning for dose-fractionated radioimmunotherapy.
Cancer 2002;94(4 Suppl):1264-9.
-
2001: DeNardo G L; DeNardo S J; Kukis D L; O'Donnell R T; Shen S; Mirick G R; Meares C F
Metabolite production in patients with lymphoma after radiometal-labeled antibody administration.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(9):1324-33.
-
2001: O'Donnell R T; DeNardo S J; Yuan A; Shen S; Richman C M; Lara P N; Griffith I J; Goldstein D S; Kukis D L; Martinez G S; Mirick G R; DeNardo G L; Meyers F J
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1561-8.
-
2000: DeNardo G L; DeNardo S J; O'Donnell R T; Kroger L A; Kukis D L; Meares C F; Goldstein D S; Shen S
Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
Clinical lymphoma 2000;1(2):118-26.
-
2000: O'Donnell R T; Shen S; Denardo S J; Wun T; Kukis D L; Goldstein D S; Denardo G L
A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
Anticancer research 2000;20(5C):3647-55.
-
2000: DeNardo G L; O'Donnell R T; Shen S; Kroger L A; Yuan A; Meares C F; Kukis D L; DeNardo S J
Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):952-8.
-
1999: Shen S; DeNardo G L; Sgouros G; O'Donnell R T; DeNardo S J
Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2102-6.
-
1999: O'Donnell R T; DeNardo G L; Kukis D L; Lamborn K R; Shen S; Yuan A; Goldstein D S; Carr C E; Mirick G R; DeNardo S J
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2014-20.
-
1999: Kukis D L; DeNardo S J; Mills S L; Shen S; O'Donnell R T; DeNardo G L
Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage.
Cancer biotherapy & radiopharmaceuticals 1999;14(5):363-9.
-
1999: Mirick G R; O'Donnell R T; DeNardo S J; Shen S; Meares C F; DeNardo G L
Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.
Nuclear medicine and biology 1999;26(7):841-5.
-
1999: O'Donnell R T; DeNardo G L; Kukis D L; Lamborn K R; Shen S; Yuan A; Goldstein D S; Mirick G R; DeNardo S J
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3330s-3336s.
-
1999: Richman C M; DeNardo S J; O'Donnell R T; Goldstein D S; Shen S; Kukis D L; Kroger L A; Yuan A; Boniface G R; Griffith I J; DeNardo G L
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3243s-3248s.
-
1999: DeNardo G L; O'Donnell R T; Kroger L A; Richman C M; Goldstein D S; Shen S; DeNardo S J
Strategies for developing effective radioimmunotherapy for solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3219s-3223s.
-
1999: DeNardo G L; DeNardo S J; Shen S; DeNardo D A; Mirick G R; Macey D J; Lamborn K R
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(8):1317-26.
-
1999: O'Donnell R T; Leigh B R; Christensen S D; Goldstein D S; Kukis D L; Shen S; Yuan A; DeNardo D A; Kroger L A; DeNardo G L
Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma.
Cancer biotherapy & radiopharmaceuticals 1999;14(3):167-76.
-
1999: Wilder R B; Shen S; DeNardo G L
Dosimetry for radioimmunotherapy: a rapidly evolving field.
Cancer biotherapy & radiopharmaceuticals 1999;14(2):67-70.
-
1999: DeNardo G L; Kukis D L; Shen S; DeNardo D A; Meares C F; DeNardo S J
67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):533-41.
-
1999: DeNardo S J; DeNardo G L; Kukis D L; Shen S; Kroger L A; DeNardo D A; Goldstein D S; Mirick G R; Salako Q; Mausner L F; Srivastava S C; Meares C F
67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):302-10.
-
1998: Denardo S J; Richman C M; Kukis D L; Shen S; Lamborn K R; Miers L A; Kroger L A; Perez E A; Denardo G L
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.
Anticancer research 1998;18(6A):4011-8.
-
1998: DeNardo G L; Kroger L A; Meares C F; Richman C M; Salako Q; Shen S; Lamborn K R; Peterson J J; Miers L A; Zhong G R; DeNardo S J
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2483-90.
-
1998: DeNardo G L; DeNardo S J; Goldstein D S; Kroger L A; Lamborn K R; Levy N B; McGahan J P; Salako Q; Shen S; Lewis J P
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3246-56.
-
1998: DeNardo G L; DeNardo S J; Lamborn K R; Goldstein D S; Levy N B; Lewis J P; O'Grady L F; Raventos A; Kroger L A; Macey D J; McGahan J P; Mills S L; Shen S
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.
Cancer biotherapy & radiopharmaceuticals 1998;13(4):239-54.
-
1998: Denardo G L; Denardo S J; Kukis D L; O'Donnell R T; Shen S; Goldstein D S; Kroger L A; Salako Q; Denardo D A; Mirick G R; Mausner L F; Srivastava S C; Meares C F
Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.
Anticancer research 1998;18(4B):2779-88.
-
1998: Shen S; DeNardo G L; Jones T D; Wilder R B; O'Donnell R T; DeNardo S J
A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(7):1223-9.
-
1998: DeNardo S J; Kukis D L; Miers L A; Winthrop M D; Kroger L A; Salako Q; Shen S; Lamborn K R; Gumerlock P H; Meares C F; DeNardo G L
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(5):842-9.
-
1998: DeNardo G L; Shen S; DeNardo S J; Liao S Q; Lamborn K R; DeNardo D A; Yuan A
Quantification of iodine-131 in tumors using a threshold based on image contrast.
European journal of nuclear medicine 1998;25(5):497-502.
-
1998: DeNardo S J; Kroger L A; MacKenzie M R; Mirick G R; Shen S; DeNardo G L
Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody.
Cancer biotherapy & radiopharmaceuticals 1998;13(1):1-12.
-
1997: DeNardo G L; Kukis D L; DeNardo S J; Shen S; Mausner L F; O'Donnell R T; Lamborn K R; Meyers F J; Srivastava S C; Miers L A
Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.
Cancer 1997;80(12 Suppl):2576-82.
-
1997: DeNardo D A; DeNardo G L; O'Donnell R T; Lim S M; Shen S; Yuan A; DeNardo S J
Imaging for improved prediction of myelotoxicity after radioimmunotherapy.
Cancer 1997;80(12 Suppl):2558-66.
-
1997: Shen S; DeNardo G L; O'Donnell R T; Yuan A; DeNardo D A; DeNardo S J
Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies.
Cancer 1997;80(12 Suppl):2553-7.
-
1997: Lim S M; DeNardo G L; DeNardo D A; Shen S; Yuan A; O'Donnell R T; DeNardo S J
Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1374-8.
-
1997: Lamborn K R; DeNardo G L; DeNardo S J; Goldstein D S; Shen S; Larkin E C; Kroger L A
Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1253-60.
-
1997: DeNardo S J; Kramer E L; O'Donnell R T; Richman C M; Salako Q A; Shen S; Noz M; Glenn S D; Ceriani R L; DeNardo G L
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1180-5.
-
1997: Shen S; DeNardo G L; Macey D J; O'Donnell R T; Yuan A; DeNardo D A; DeNardo S J
Practical determination of organ S values for individual patients for therapy.
Nuclear medicine and biology 1997;24(5):447-9.
-
1997: Denardo S J; Richman C M; Goldstein D S; Shen S; Salako Q; Kukis D L; Meares C F; Yuan A; Welborn J L; Denardo G L
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.
Anticancer research 1997;17(3B):1735-44.
-
1997: DeNardo G L; Kukis D L; Shen S; Mausner L F; Meares C F; Srivastava S C; Miers L A; DeNardo S J
Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):71-9.
-
1997: Shen S; DeNardo G L; DeNardo S J; Yuan A; DeNardo D A; Lamborn K R
Reproducibility of operator processing for radiation dosimetry.
Nuclear medicine and biology 1997;24(1):77-83.
-
1996: DeNardo D A; DeNardo G L; Yuan A; Shen S; DeNardo S J; Macey D J; Lamborn K R; Mahe M; Groch M W; Erwin W D
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):1970-5.
-
1996: Wilder R B; DeNardo G L; Sheri S; Fowler J F; Wessels B W; DeNardo S J
Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy.
European journal of nuclear medicine 1996;23(8):953-7.
-
1996: Erwin W D; Groch M W; Macey D J; DeNardo G L; DeNardo S J; Shen S
A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy.
Nuclear medicine and biology 1996;23(4):525-32.
-
1996: DeNardo G L; Kukis D L; Shen S; DeNardo S J
Accurate measurement of copper-67 in the presence of copper-64 contaminant using a dose calibrator.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(2):302-6.
-
1996: Shen S; DeNardo G L; DeNardo S J; Salako Q; Morris G; Banks D; Yuan A; DeNardo D A
Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):146-50.
-
1995: DeNardo G L; Lamborn K R; DeNardo S J; Goldstein D S; Dolber-Smith E G; Kroger L A; Larkin E C; Shen S
Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.
Cancer research 1995;55(23 Suppl):5893s-5898s.
-
1995: DeNardo S J; Gumerlock P H; Winthrop M D; Mack P C; Chi S G; Lamborn K R; Shen S; Miers L A; deVere White R W; DeNardo G L
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
Cancer research 1995;55(23 Suppl):5837s-5841s.
-
1995: Macey D J; DeNardo S J; DeNardo G L; DeNardo D A; Shen S
Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy.
Clinical nuclear medicine 1995;20(2):117-25.
-
1994: Shen S; DeNardo G L; DeNardo S J
Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter.
Medical physics 1994;21(9):1409-17.
-
1994: Shen S; DeNardo G L; Yuan A; DeNardo D A; DeNardo S J
Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(8):1381-9.
-
1994: DeNardo G L; DeNardo S J; Macey D J; Shen S; Kroger L A
Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131I-Lym-1 as a model.
Cancer 1994;73(3 Suppl):1038-48.
-
1994: DeNardo G L; Kroger L A; DeNardo S J; Miers L A; Salako Q; Kukis D L; Fand I; Shen S; Renn O; Meares C F
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).
Cancer 1994;73(3 Suppl):1012-22.
-
1990: Yeh Y; Baskin R J; Shen S; Jones M
Photon correlation spectroscopy of the polarization signal from single muscle fibres.
Journal of muscle research and cell motility 1990;11(2):137-46.
-
1989: Chen J S; Baskin R J; Baskin R J; Burton K; Shen S; Yeh Y
Polarization states of diffracted light. Changes accompanying fiber activation.
Biophysical journal 1989;56(3):595-605.
Sign-in to see more
